Cholestasis, progressive familial intrahepatic 3
|
0.770 |
Biomarker
|
disease |
BEFREE |
Here, we report results from treating two- or five-week-old Abcb4<sup>-/-</sup> mice with an AAV vector expressing human ABCB4, resulting in significant decreases of PFIC3 disease biomarkers.
|
31836711 |
2019 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Patients 2 and 3 were diagnosed with MDR3 deficiency due to recessive mutations in ABCB4.
|
31000363 |
2019 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
Biomarker
|
disease |
BEFREE |
In conclusion, the obtained results suggest that some synonymous SNPs in the ABCB4 gene, considered up to now as neutral, may be involved in the MDR3 deficiency.
|
30079523 |
2018 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
Biomarker
|
disease |
BEFREE |
Herein, we report a case of severe MDR3 deficiency in a male child diagnosed with negative MDR3 immunostaining in hepatic canaliculi who underwent LDLT at our centre.
|
28127842 |
2017 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Functional defect of variants in the adenosine triphosphate-binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX-770).
|
28012258 |
2017 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
Biomarker
|
disease |
CTD_human |
8-Methoxypsoralen disrupts MDR3-mediated phospholipids efflux and bile acid homeostasis and its relevance to hepatotoxicity.
|
28552422 |
2017 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
In silico investigation of the impact of synonymous variants in ABCB4 gene on mRNA stability/structure, splicing accuracy and codon usage: Potential contribution to PFIC3 disease.
|
27788395 |
2016 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
Biomarker
|
disease |
BEFREE |
Herein, we report the clinical and histopathologic features of 10 cases (6 male/4 female) in infants and children with severe MDR3 deficiency (age range of 8 months to 7 years) diagnosed with negative MDR3 immunostaining in hepatic canaliculi.
|
26117383 |
2015 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.
|
24594635 |
2015 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunction.
|
24045840 |
2014 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4.
|
24806754 |
2014 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
Biomarker
|
disease |
CTD_human |
Effects of cellular, chemical, and pharmacological chaperones on the rescue of a trafficking-defective mutant of the ATP-binding cassette transporter proteins ABCB1/ABCB4.
|
22184139 |
2012 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations.
|
21119540 |
2011 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
GermlineCausalMutation
|
disease |
ORPHANET |
Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations.
|
21119540 |
2011 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
We report the molecular characterization of 68 PFIC3 index cases enrolled in a multicenter study, which represents the largest cohort of PFIC3 patients screened for ABCB4 mutations to date.
|
17726488 |
2007 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
GermlineCausalMutation
|
disease |
ORPHANET |
We report the molecular characterization of 68 PFIC3 index cases enrolled in a multicenter study, which represents the largest cohort of PFIC3 patients screened for ABCB4 mutations to date.
|
17726488 |
2007 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
We report the molecular characterization of 68 PFIC3 index cases enrolled in a multicenter study, which represents the largest cohort of PFIC3 patients screened for ABCB4 mutations to date.
|
17726488 |
2007 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Although biliary cirrhosis associated with MDR3 deficiency typically appears before the age of 25 years, in our case, the relatively mild MDR3 dysfunction allowed for a slower progression of the disease with established, well-advanced cirrhosis in the fifth decade of life.
|
12671900 |
2003 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.
|
11313315 |
2001 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis.
|
9419367 |
1998 |
Cholestasis, progressive familial intrahepatic 3
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
|
|
|